Lifeboat Foundation

Chptr, an app for sharing and holding onto memories of lost loved ones, has raised $1.5 million in seed funding. The app is designed to give people a way to encapsulate the life of their loved ones by inviting others to share and store stories, images, audio messages, videos and more all in one place.

The startup was founded in 2020 by Rehan Choudhry, who came up with the idea for the app when he was helping his wife, a news anchor at CBS New York, put together video tributes for the first victims of COVID-19 in New York City. Choudhry told TechCrunch in an interview that the pair was reaching out to the families, friends, neighbors and colleagues of the victims to paint a picture of what their life was like.

“The thing I realized after talking to a lot of families was that these videos served as almost a reunion point for people that they will continue to grieve around,” Choudhry said. “We noticed that the grieving process that would normally take 90 days was extended to months because they had something to rally around. So then the question for me was why doesn’t everyone on the planet have access to this because we all have smartphones and social media. So I went down the rabbit hole of discovery and it brought me to Chptr.”

Blocking how cancer cells acquire and use energy, or their metabolism, as a treatment has been challenging, Dr. Lyssiotis explained. But a better understanding of how cancer cells adapt their metabolism in the often oxygen-and nutrient-deprived environments in which they exist, he said, may open other avenues for attacking them.

Identifying alternative sources of energy for cancer cells

Pancreatic cancer is one of the leading causes of death from cancer. Not only does its stark microenvironment thwart the entry of drugs designed to kill tumors, but numerous studies have shown that other residents in and around the tumors create an ecosystem that help the tumors thrive.

Elon Musk’s Neuralink is looking for a volunteer for its first clinical trial of a brain implant chip. The trial, which begins next year, has attracted thousands of prospective patients. The ideal candidate must be an adult under 40 with all four limbs paralyzed. The procedure involves inserting electrodes and wires into the brain, with a small computer replacing part of the skull. The computer will collect and analyze brain activity, sending the data wirelessly to a nearby device. Neuralink aims to translate thoughts into computer commands. However, the company has faced criticism for animal testing practices.

The system shows potential for drug development in delicate environments such as coral reefs.

ACS

To better comprehend this, researchers have presented a proof-of-concept device that “sniffs” seawater, capturing dissolved chemicals for analysis. The underwater device “catches and concentrates dissolved substances generated by sponges or other marine animals while causing no damage to the source or the environment,” said a statement.

Continue reading “Deep-sea sniffer dog? Scientists develop device to detect new molecules” »

The hope is that people who are unable to speak because of neurological conditions may one day be able to communicate again thanks to this modern technology.

Helping people with motor disorders

“There are many patients who suffer from debilitating motor disorders, like ALS (amyotrophic lateral sclerosis) or locked-in syndrome, that can impair their ability to speak,” said Gregory Cogan, Ph.D., a professor of neurology at Duke University’s School of Medicine and one of the lead researchers involved in the project.

Continue reading “Brain implant turns thoughts into speech with up to 84% accuracy” »

The first rub-on gene therapy shows how biotech companies are getting creative with how they deliver DNA fixes.

Designer chromosomes enable new studies of genome organization and evolution.

The synthesized yeast strain contains over 50% synthetic DNA and survives and replicates much like wild-type S. cerevisiae.

A new map of 56,000 cells in the outer layer of the human brain could inform research into a whole class of diseases.